Key regions: France, Australia, India, South Korea, Germany
The Other OTC Pharmaceuticals (Pharmacies) market in Egypt is experiencing significant growth and development.
Customer preferences: Customers in Egypt have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience of purchasing these products without a prescription, the increasing awareness of self-medication, and the affordability of OTC medicines compared to prescription drugs. Additionally, the availability of a wide range of OTC pharmaceuticals in local pharmacies has also contributed to the growing demand.
Trends in the market: One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Egypt is the increasing adoption of generic OTC medicines. Generic medicines are more affordable compared to branded products, making them an attractive option for cost-conscious consumers. The government's efforts to promote the use of generic medicines and the presence of local manufacturers offering generic OTC pharmaceuticals have further fueled this trend. Another trend in the market is the growing demand for natural and herbal OTC products. Consumers in Egypt are increasingly seeking natural remedies and are willing to try alternative therapies for common ailments. This has led to the introduction of a wide range of natural and herbal OTC products in pharmacies across the country.
Local special circumstances: Egypt has a large population and a high burden of diseases, which has contributed to the growth of the OTC Pharmaceuticals (Pharmacies) market. The healthcare infrastructure in the country is still developing, and access to healthcare services, including doctors and hospitals, can be limited in certain areas. As a result, consumers often rely on pharmacies as their primary source of healthcare advice and treatment. This has created a favorable environment for the growth of the OTC Pharmaceuticals (Pharmacies) market.
Underlying macroeconomic factors: The Egyptian economy has been growing steadily in recent years, which has had a positive impact on the purchasing power of consumers. As disposable incomes increase, consumers are more willing to spend on healthcare products, including OTC pharmaceuticals. Additionally, the government's focus on improving healthcare services and increasing healthcare spending has also contributed to the growth of the OTC Pharmaceuticals (Pharmacies) market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Egypt is developing due to the growing customer preferences for OTC medicines, the increasing adoption of generic and natural products, the reliance on pharmacies for healthcare services, and the underlying macroeconomic factors such as economic growth and government initiatives.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
